AUBH2013 Scientific Agenda

NAI LERT PARK
Swissotel
Bangkok, Thailand

Registration Desk Opens: 6:00 AM- 4:00 PM 

Scientific Agenda

Day 1 August 30, 2013
8:30 AM- 8:45 AM: Inauguration session
APHCON Update: Surapol Issaragrisil
ASEAN Cancer Research: Niwat Boonyuen
The Thai Society of Hematology: Wanchai Wanachiwanawin
8:45 AM- 9:05 AM: Kian Ang Memorial Lecture
Building Bridges Across Nations with Clinical Trials
Borje Andersson, USA

9:05 AM - 10:15 AM: Plenary Lecture - I
Chair: Surapol Issaragrisil and Simrit Parmar
Treatment of Adult Acute Lymphoblastic Leukemia (ALL) With a Focus on Emerging Investigational and Targeted Therapies
Jorge Cortes, USA
Drug of Choice for Chronic Myelogenous Leukemia?
Tapan Kadia, USA

10:15 AM- 10:30 AM
Coffee Break/ Exhibit Booth

10:30 AM - 12:00 PM: Debate Session-1
Chair: Wanchai Wanachiwanawin and Hemant Malhotra
Is 7+3 still the induction regimen for Acute Myeloid Leukemia patients?
Yes: Tapan Kadia, USA
No: JianXiang Wang, China
Upfront Treatment with hypomethylating agents in Elderly Acute Myeloid Leukemia vs. Induction?
Yes: David Ritchie, Australia
No: Subhash Varma, India
Is there a Possibility to Cure Acute Promyelocytic Leukemia without chemotherapy in the future? 
Yes: Auro Viswabandya , India
No: Jiong Hu, China

12:00 PM - 1:00 PM LUNCH

1:00 PM - 2:00 PM Plenary Session-2
Chair: JianXiang Wang and Pankaj Malhotra
Treatment Breakthroughs in Chronic Lymphocytic Leukemia
Jane Huang, USA
Targeted Therapy in Hodgkin's Lymphoma
David Ritchie, Australia
Updates on Treatment of Chronic ITP
Raymond Wong, Hong Kong

2:00 PM - 3:00 PM Debate Session-2
Chair: William Hwang and Deepak Mishra
Philadelphia +ve Acute Lymphocytic Leukemia: Upfront Transplant?
Yes: Jorge Cortes, USA
No: Pankaj Malhotra
High Risk MDS: Upfront Transplant?
Yes: Tapan Kadia, USA
No: Suporn Chancharunee, Thailand

3:00 PM - 3:30 PM: Coffee Break

3:30 PM - 5:00 PM Debate Session - 3
Chair: Noppadol Siritanaratkul and Subhash Varma
Is Imatinib still the Preferred Frontline Treatment for Newly Diagnosed Chronic Phase-Chronic Myelogenous Leukemia patients?
Yes: Jorge Cortes, USA
No: Hemant Malhotra, India
Alternative Donor Transplant for Aplastic Anemia
Yes: Seiji Kojima, Japan
No: William Hwang, Singapore
Therapy for adult thalassemia
Transplant:  Suradej Hongeng, Thailand
Hypertransfusion and Chelation: Noppadol Siritanaratkul, Thailand

5:00 PM : Adjourn

Day 2: August 31, 2013
8:30 AM - 10:00 AM: Plenary Session -3
Chair: Ying-Jun Chang and Borje Andersson
Special Lecture: 'Reaching Out to Patients'
Jorge Cortes, USA
Advances in Myeloma Treatment
James Chim, Hong Kong
Autologous vs. Allogeneic Stem Cell Transplant for Multiple Myeloma
Uday Popat, USA

10:00 AM- 10:30 AM
Coffee Break/ Exhibit Booth

10:30 AM - 12:00 PM: Debate Session-4
Chair: Suradej Hongeng and Simrit Parmar
What is the best approach in Relapsed Hodgkin's Lymphoma patients who achieve CR with Brentuximab Vedotin after failing Autologous Stem Cell Transplant?
Immediate Allo-SCT: Borje Andersson, USA
Delayed Allo-SCT: David Ritchie, Australia
Peripheral T cell lymphoma
Targeted Therapy: Subhash Varma, India
Upfront Transplant: Uday Popat, USA
Relapsed Follicular Lymphoma
Upfront Autologous Stem Cell Transplant: Auro Viswabandya, India
Upfront Allogeneic Stem Cell Transplant: Uday Popat, USA

12:00 PM - 1:00 PM LUNCH

1:00 PM - 2:00 PM: Plenary Session 4
Chair: Seiji Kojima and Aye Aye Gyi
Advances in Stem Cell Transplant: Past, Present and Future
Borje Andersson, USA
Haploidentical stem cell transplantation: the underlying mechanisms of crossing human leukocyte antigen barriers
Ying-Jun Chang, China

2:00 PM - 3:00 PM Debate Session-5
Chair: James Chim and Auro Viswabandya
Post Transplant Maintenance in High Risk Multiple Myeloma
Yes: Pankaj Malhotra, India
No: Achrob Khuhapinant, Thailand
Is it Better to Omit Anti-Thymocyte Globulin in the Conditioning Regimen for Matched Unrelated Donor Transplant?
Yes: David Ritchie, Australia
No: Borje Andersson, USA
Haploidentical vs. Matched Unrelated Donor Transplant
Haplo: Uday Popat, USA
MUD: Seiji Kojima, Japan
Haploidentical vs. Cord Blood Transplant
Haplo: Ying-Jun Chang, China
Cord: William Hwang, Singapore

3:30 PM - 4:00 PM: Coffee Break

4:00 PM - 5:00 PM : Meet The Expert Session/ Simultaneous session
Borje Andersson, USA (Transplant)
Jorge Cortes, USA (CML)
Tapan Kadia (AML)
Uday Popat, USA (Myeloma and Transplant)

Home
AUBH2013 Home
Conference Information
Faculty
AUBH Agenda
Registration
Abstract Submission
Contact Us
BTG2014
AUBH2013